08:00 , Feb 6, 2006 |  BioCentury  |  Product Development

Breathless opportunities

Treatment of asthma has remained essentially unchanged for years and focuses on alleviating symptoms rather than disease modification. In large part, the state of the art reflects inertia on the part of the dominant big...
07:00 , Jul 15, 2002 |  BC Week In Review  |  Company News

Genome Therapeutics, Schering-Plough other research news

Researchers published in Nature evidence that ADAM33 is involved in the etiology of asthma. Genome-wide analysis of 460 Caucasian families identified a link between the 20p13 locus and asthma and bronchial hyper-responsiveness. Haplotype analysis of...